Cargando…

Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics

Mutations within the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are the most common genetic cause of autosomal and sporadic Parkinson’s disease (PD). LRRK2 is a large multidomain kinase that has reported interactions with several membrane proteins, including Rab and Endophilin, and has recently been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanstrum, Bethany J., Goo, Brandee M. S. S., Holden, Diana Z. Y., Delgado, Donovan D., Nguyen, Thien P. N., Lee, Kiana D., James, Nicholas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321188/ https://www.ncbi.nlm.nih.gov/pubmed/32486414 http://dx.doi.org/10.3390/molecules25112561

Ejemplares similares

Arc/Arg3.1 has an activity-regulated interaction with PICK1 that results in altered spatial dynamics
por: Goo, Brandee M. S. S., et al.
Publicado: (2018)

Mitochondrial Mechanisms of LRRK2 G2019S Penetrance
por: Delcambre, Sylvie, et al.
Publicado: (2020)

LRRK2‐G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons
por: Skiteva, Olga, et al.
Publicado: (2022)

Age- and Sex-Dependent Behavioral and Neurochemical Alterations in hLRRK2-G2019S BAC Mice
por: Yao, Ning, et al.
Publicado: (2022)

Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021)

Differential LRRK2 signalling and gene expression in WT-LRRK2 and G2019S-LRRK2 mouse microglia treated with zymosan and MLi2
por: Nazish, Iqra, et al.
Publicado: (2023)

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
por: San Luciano, Marta, et al.
Publicado: (2017)

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
por: Beccano-Kelly, Dayne A., et al.
Publicado: (2014)

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson’s Disease?
por: Ren, Chao, et al.
Publicado: (2019)

Commentary on “Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice”
por: Popugaeva, Elena, et al.
Publicado: (2014)

Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues
por: Iannotta, Lucia, et al.
Publicado: (2020)

R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations
por: Xenias, Harry S., et al.
Publicado: (2022)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients
por: Duque, Andrés Felipe, et al.
Publicado: (2015)

Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
por: Saunders-Pullman, Rachel, et al.
Publicado: (2014)

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
por: Bouhouche, Ahmed, et al.
Publicado: (2017)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons
por: Fellgett, Alison, et al.
Publicado: (2021)

Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S Patients
por: Mabrouk, Omar S., et al.
Publicado: (2020)

Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
por: Singh, Francois, et al.
Publicado: (2021)

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2(G2019S)-Parkinson’s disease
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2018)

Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
por: Schwab, Andrew J., et al.
Publicado: (2017)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
por: Carola, G., et al.
Publicado: (2021)

An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
por: Padmanabhan, Shalini, et al.
Publicado: (2020)

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
por: Nguyen, An Phu Tran, et al.
Publicado: (2020)

LRRK2 p.G2019S Mutation Is Not Common among Alzheimer’s Disease Patients in Brazil
por: Santos-Rebouças, Cíntia Barros, et al.
Publicado: (2009)

LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
por: Choi, Insup, et al.
Publicado: (2015)

Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
por: Kim, Hongwon, et al.
Publicado: (2019)

CAV-2-Mediated GFP and LRRK2(G2019S) Expression in the Macaca fascicularis Brain
por: di Caudo, Carla, et al.
Publicado: (2020)

Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers
por: Garrido, Alicia, et al.
Publicado: (2022)

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
por: Corral Nieto, Yaiza, et al.
Publicado: (2023)

Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects
por: Borgs, Laurence, et al.
Publicado: (2016)

The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy
por: Cho, Jin-Whan, et al.
Publicado: (2009)

G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
por: Ho, Dong Hwan, et al.
Publicado: (2019)

Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort
por: Landoulsi, Zied, et al.
Publicado: (2017)

A patient clinically diagnosed as multiple system atrophy harboring LRRK2 p.G2019S
por: Ando, Shoichiro, et al.
Publicado: (2019)

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2022)

Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
por: Garrido, Alicia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vh0tg8qmh6p5cr73r1lb0kvg7e